The acquisition, approved by Kroger’s board, is expected to become accretive to adjusted earnings per share by the second full year following its close. Kroger anticipates completing the transaction next year, pending regulatory approval. To satisfy antitrust requirements, the companies expect to divest a limited number of Giant Eagle locations.

Giant Eagle, founded in 1931, brings approximately $9 billion in annual sales and 11 standalone pharmacies to the Kroger portfolio. CEO Greg Foran cited the regional chain's strong customer loyalty and reputation for fresh products as primary drivers for the acquisition. This purchase aligns with Kroger’s broader strategy of capital allocation and targeted growth within the competitive retail pharmacy and grocery sector.